<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<ep-patent-document id="EP10184938B8W1" file="EP10184938W1B8.xml" lang="en" country="EP" doc-number="2363404" kind="B8" correction-code="W1" date-publ="20161207" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEE....SK....................................</B001EP><B005EP>J</B005EP><B007EP>JDIM360 Ver 1.28 (29 Oct 2014) -  2999001/0</B007EP></eptags></B000><B100><B110>2363404</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20161207</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>10184938.8</B210><B220><date>20021023</date></B220><B240><B241><date>20120725</date></B241><B242><date>20130211</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>335215 P</B310><B320><date>20011023</date></B320><B330><ctry>US</ctry></B330><B310>362747 P</B310><B320><date>20020307</date></B320><B330><ctry>US</ctry></B330><B310>412618 P</B310><B320><date>20020920</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20161207</date><bnum>201649</bnum></B405><B430><date>20110907</date><bnum>201136</bnum></B430><B450><date>20160907</date><bnum>201636</bnum></B450><B452EP><date>20160309</date></B452EP><B480><date>20161207</date><bnum>201649</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07H  21/04        20060101AFI20111219BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C12N   5/12        20060101ALI20111219BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>C07K  16/00        20060101ALI20111219BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>A61K  39/395       20060101ALI20111219BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>G01N  33/53        20060101ALI20111219BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>A61K  51/10        20060101ALI20111219BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>C07K  16/30        20060101ALI20111219BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>PSMA Antikörper</B542><B541>en</B541><B542>PSMA antibodies</B542><B541>fr</B541><B542>Anticorps contre le PSMA</B542></B540><B560><B561><text>WO-A-01/09192</text></B561><B562><text>DONOVAN G P ET AL: "ANTIBODY AND VACCINE THERAPIES TARGETING PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA)", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, vol. 42, 24 March 2001 (2001-03-24), page 818, XP001204629, ISSN: 0197-016X</text></B562><B562><text>HOLMES E H: "PSMA specific antibodies and their diagnostic and therapeutic use", EXPERT OPINION ON INVESTIGATIONAL DRUGS, ASHLEY PUBLICATIONS LTD., LONDON, GB, vol. 10, no. 3, March 2001 (2001-03), pages 511-519, XP002988381, ISSN: 1354-3784</text></B562><B562><text>LIU H ET AL: "MONOCLONAL ANTIBODIES TO THE EXTRACELLULAR DOMAIN OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN ALSO REACT WITH TUMOR VASCULAR ENDOTHELIUM", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 57, no. 17, 1 September 1997 (1997-09-01), pages 3629-3634, XP001080132, ISSN: 0008-5472</text></B562><B562><text>GONG M C ET AL: "Prostate-specific membrane antigen (PMSA)-specific monoclonal antibodies in the treatment of prostate and other cancers", CANCER AND METASTASIS REVIEWS, KLUWER ACADEMIC PUBLISHERS, DORDRECHT, NL, vol. 18, no. 4, 1999, pages 483-490, XP002982445, ISSN: 0167-7659</text></B562><B562><text>SMITH-JONES P M ET AL: "In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 60, no. 18, 15 September 2000 (2000-09-15), pages 5237-5243, XP002327842, ISSN: 0008-5472</text></B562><B562><text>LAPIDUS RENA G ET AL: "Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells", PROSTATE, WILEY-LISS, NEW YORK, NY, US, vol. 45, no. 4, 1 December 2000 (2000-12-01), pages 350-354, XP009026666, ISSN: 0270-4137</text></B562><B562><text>TINO WILLIAM T ET AL: "Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA)", HYBRIDOMA, vol. 19, no. 3, June 2000 (2000-06), pages 249-257, XP002397386, ISSN: 0272-457X</text></B562><B562><text>SCHULKE N ET AL: "The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 100, no. 22, 28 October 2003 (2003-10-28), pages 12590-12595, XP002323660, ISSN: 0027-8424</text></B562></B560></B500><B600><B620><parent><pdoc><dnum><anum>02802198.8</anum><pnum>1448588</pnum></dnum><date>20021023</date></pdoc></parent></B620><B620EP><parent><cdoc><dnum><anum>16187305.4</anum></dnum><date>20160905</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>Maddon, Paul, J.</snm><adr><str>191 Fox Meadow Road</str><city>Scarsdale, NY 10583</city><ctry>US</ctry></adr></B721><B721><snm>Donovan Gerald</snm><adr><str>1 Siler Lake Road</str><city>Kittery, ME 03904</city><ctry>US</ctry></adr></B721><B721><snm>Olson, William</snm><adr><str>815 Locke Lane</str><city>Yorktown Heights, NY 10598</city><ctry>US</ctry></adr></B721><B721><snm>Schulke, Norbert</snm><adr><str>37 Olympic Court</str><city>East Walpole, MA 02032</city><ctry>US</ctry></adr></B721><B721><snm>Gardner, Jason</snm><adr><str>320 Trillium Lane</str><city>Wayne, PA 19087</city><ctry>US</ctry></adr></B721><B721><snm>Ma, Dangshe</snm><adr><str>49 Gienwood Road</str><city>Millwood NY 10546</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>PSMA Development Company L.L.C.</snm><iid>101612213</iid><irf>TSJ/45887EP2</irf><adr><str>One World Trade Center 
47th Floor Suite J</str><city>New York, NY 10007</city><ctry>US</ctry></adr></B731><B731><snm>Amgen Fremont Inc.</snm><iid>101246542</iid><irf>TSJ/45887EP2</irf><adr><str>One Amgen Center Drive</str><city>Thousand Oaks, CA 91320-1799</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Jump, Timothy John Simon</snm><sfx>et al</sfx><iid>101235871</iid><adr><str>Venner Shipley LLP 
200 Aldersgate</str><city>London EC1A 4HD</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20120725</date></B845EP><B845EP><ctry>LT</ctry><date>20120725</date></B845EP><B845EP><ctry>LV</ctry><date>20120725</date></B845EP><B845EP><ctry>MK</ctry><date>20120725</date></B845EP><B845EP><ctry>RO</ctry><date>20120725</date></B845EP><B845EP><ctry>SI</ctry><date>20120725</date></B845EP></B844EP><B880><date>20120125</date><bnum>201204</bnum></B880></B800></SDOBI>
</ep-patent-document>
